$OTLC News Out - today announced that PDAOAI, the Company's AI-powered drug discovery platform, is inviting scientists, AI developers and biotech founders to participate in BIO REBOOT. The invitation accompanies two keynote presentations at Drug Discovery 2026, including a hepatocellular carcinoma case study illustrating how Partitioned Literature Aggregation can generate testable research hypotheses.
BIO REBOOT Opens Registration
Through BIO REBOOT, individuals and teams can bring research questions, technical expertise and drug discovery ideas to the PDAOAI community. Registration is free at
https://pdaoai.com/bio-reboot.
https://finance.yahoo.com/healthcare/articles...00006.html